Association of ADAMTS Proteoglycanases Downregulation with IVF-ET Outcomes in Patients with Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis

Overview

Journal Reprod Biol Endocrinol

Publisher Biomed Central

Specialties Endocrinology
Reproductive Medicine

Date 2022 Dec 12

PMID 36510316

Authors

Yanbin Shi

Yang Shi

Guiyuan He

Guang Wang

Hongbo Liu

Xiaoguang Shao

Affiliations

Soon will be listed here.

Abstract

Background: A disintegrin and metalloproteinase with thrombospondin-like motifs (ADAMTS) is involved in inflammation and fertility in women with polycystic ovary syndrome (PCOS). This study aims to assess the role of ADAMTS level in the outcomes of in vitro fertilization and embryo transfer (IVF-ET) in women with PCOS, using a meta-analytic approach.

Methods: We systematically searched Web of Science, PubMed, EmBase, and the Cochrane library to identify potentially eligible studies from inception until December 2021. Study assess the role of ADAMTS levels in patients with PCOS was eligible in this study. The pooled effect estimates for the association between ADAMTS level and IVF-ET outcomes were calculated using the random-effects model.

Results: Five studies involving a total of 181 patients, were selected for final analysis. We noted that ADAMTS-1 levels were positively correlated to oocyte maturity (r = 0.67; P = 0.004), oocyte recovery (r = 0.74; P = 0.006), and fertilization (r = 0.46; P = 0.041) rates. Moreover, ADAMTS-4 levels were positively correlated to oocyte recovery (r = 0.91; P = 0.001), and fertilization (r = 0.85; P = 0.017) rates. Furthermore, downregulation of ADAMTS-1, ADAMTS-4, ADAMTS-5, and ADAMTS-9 was associated with elevated follicle puncture (ADAMTS-1: weighted mean difference [WMD], 7.24, P < 0.001; ADAMTS-4: WMD, 7.20, P < 0.001; ADAMTS-5: WMD, 7.20, P < 0.001; ADAMTS-9: WMD, 6.38, P < 0.001), oocytes retrieval (ADAMTS-1: WMD, 1.61, P < 0.001; ADAMTS-4: WMD, 3.63, P = 0.004; ADAMTS-5: WMD, 3.63, P = 0.004; ADAMTS-9: WMD, 3.20, P = 0.006), and Germinal vesicle oocytes levels (ADAMTS-1: WMD, 2.89, P < 0.001; ADAMTS-4: WMD, 2.19, P < 0.001; ADAMTS-5: WMD, 2.19, P < 0.001; ADAMTS-9: WMD, 2.89, P < 0.001). Finally, the oocytes recovery rate, oocyte maturity rate, fertilization rate, cleavage rate, good-quality embryos rate, blastocyst formation rate, and clinical pregnancy rate were not affected by the downregulation of ADAMTS-1, ADAMTS-4, ADAMTS-5, and ADAMTS-9 (P > 0.05).

Conclusions: This study found that the outcomes of IVF-EF in patients with PCOS could be affected by ADAMTS-1 and ADAMTS-4; further large-scale prospective studies should be performed to verify these results.

Citing Articles

Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases, and Their Ratios in Women with Polycystic Ovary Syndrome and Healthy Controls.

Butler A, Nandakumar M, Sathyapalan T, Brennan E, Atkin S Int J Mol Sci. 2025; 26(1.

PMID: 39796177 PMC: 11720512. DOI: 10.3390/ijms26010321.

References

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

Zhang Y, Ouyang X, You S, Zou H, Shao X, Zhang G . Effect of human amniotic epithelial cells on ovarian function, fertility and ovarian reserve in primary ovarian insufficiency rats and analysis of underlying mechanisms by mRNA sequencing. Am J Transl Res. 2020; 12(7):3234-3254. PMC: 7407690. View

Xiao S, Li Y, Li T, Chen M, Xu Y, Wen Y . Evidence for decreased expression of ADAMTS-1 associated with impaired oocyte quality in PCOS patients. J Clin Endocrinol Metab. 2014; 99(6):E1015-21. DOI: 10.1210/jc.2013-4177. View

Huang J, Chen P, Xiang Y, Liang Q, Wu T, Liu J . Gut microbiota dysbiosis-derived macrophage pyroptosis causes polycystic ovary syndrome via steroidogenesis disturbance and apoptosis of granulosa cells. Int Immunopharmacol. 2022; 107:108717. DOI: 10.1016/j.intimp.2022.108717. View

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

Tola E, Karatopuk D, Koroglu N, Ergin M, Oral H . Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome. J Assist Reprod Genet. 2017; 34(6):811-816. PMC: 5445050. DOI: 10.1007/s10815-017-0913-7. View

Adriaenssens T, Wathlet S, Segers I, Verheyen G, de Vos A, Van der Elst J . Cumulus cell gene expression is associated with oocyte developmental quality and influenced by patient and treatment characteristics. Hum Reprod. 2010; 25(5):1259-70. DOI: 10.1093/humrep/deq049. View

Lauritsen M, Bentzen J, Pinborg A, Loft A, Forman J, Thuesen L . The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod. 2014; 29(4):791-801. DOI: 10.1093/humrep/det469. View

Palomba S, Piltonen T, Giudice L . Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2020; 27(3):584-618. DOI: 10.1093/humupd/dmaa051. View

10.

Huang-Doran I, Kinzer A, Jimenez-Linan M, Thackray K, Harris J, Adams C . Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance. J Clin Endocrinol Metab. 2021; 106(8):2367-2383. PMC: 8277216. DOI: 10.1210/clinem/dgab275. View

11.

Gebhardt K, Feil D, Dunning K, Lane M, Russell D . Human cumulus cell gene expression as a biomarker of pregnancy outcome after single embryo transfer. Fertil Steril. 2011; 96(1):47-52.e2. DOI: 10.1016/j.fertnstert.2011.04.033. View

12.

Madan P, Bridges P, Komar C, Beristain A, Rajamahendran R, Fortune J . Expression of messenger RNA for ADAMTS subtypes changes in the periovulatory follicle after the gonadotropin surge and during luteal development and regression in cattle. Biol Reprod. 2003; 69(5):1506-14. DOI: 10.1095/biolreprod.102.013714. View

13.

Robker R, Russell D, ESPEY L, Lydon J, OMalley B, Richards J . Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc Natl Acad Sci U S A. 2000; 97(9):4689-94. PMC: 18294. DOI: 10.1073/pnas.080073497. View

14.

Rosewell K, Al-Alem L, Zakerkish F, McCord L, Akin J, Chaffin C . Induction of proteinases in the human preovulatory follicle of the menstrual cycle by human chorionic gonadotropin. Fertil Steril. 2014; 103(3):826-33. PMC: 4346449. DOI: 10.1016/j.fertnstert.2014.11.017. View

15.

Gleicher N, Darmon S, Molinari E, Patrizio P, Barad D . Importance of IGF-I levels in IVF: potential relevance for growth hormone (GH) supplementation. J Assist Reprod Genet. 2022; 39(2):409-416. PMC: 8956770. DOI: 10.1007/s10815-021-02379-8. View

16.

Su N, Huang C, Liu J, Kang D, Wang S, Liao L . Association between baseline LH/FSH and live-birth rate after fresh-embryo transfer in polycystic ovary syndrome women. Sci Rep. 2021; 11(1):20490. PMC: 8516967. DOI: 10.1038/s41598-021-99850-4. View

17.

Boerboom D, Russell D, Richards J, Sirois J . Regulation of transcripts encoding ADAMTS-1 (a disintegrin and metalloproteinase with thrombospondin-like motifs-1) and progesterone receptor by human chorionic gonadotropin in equine preovulatory follicles. J Mol Endocrinol. 2003; 31(3):473-85. DOI: 10.1677/jme.0.0310473. View

18.

McCartney C, Marshall J . CLINICAL PRACTICE. Polycystic Ovary Syndrome. N Engl J Med. 2016; 375(1):54-64. PMC: 5301909. DOI: 10.1056/NEJMcp1514916. View

19.

Demircan K, Topcu V, Takigawa T, Akyol S, Yonezawa T, Ozturk G . ADAMTS4 and ADAMTS5 knockout mice are protected from versican but not aggrecan or brevican proteolysis during spinal cord injury. Biomed Res Int. 2014; 2014:693746. PMC: 4101972. DOI: 10.1155/2014/693746. View

20.

Palomba S, Daolio J, La Sala G . Oocyte Competence in Women with Polycystic Ovary Syndrome. Trends Endocrinol Metab. 2016; 28(3):186-198. DOI: 10.1016/j.tem.2016.11.008. View